Terms: = Gastric cancer AND BRIP1, MGC126521, 83990, ENSG00000136492, FANCJ, FLJ90232, Q9BX63, MGC126523, OF AND Prognosis
54 results:
1. Narrative Review of Probiotic Use on the Recovery of Postoperative Patients with Esophageal cancer.
Co EL; Hameed M; Sebastian SA; Garg T; Sudan S; Bheemisetty N; Mohan B
Curr Nutr Rep; 2023 Dec; 12(4):635-642. PubMed ID: 37605086
[TBL] [Abstract] [Full Text] [Related]
2. Neoadjuvant and adjuvant approaches in gastroesophageal cancers.
Scheck MK; Masetti M; Lorenzen S
Curr Opin Oncol; 2023 Jul; 35(4):318-325. PubMed ID: 37222198
[TBL] [Abstract] [Full Text] [Related]
3. A nine-gene signature as prognostic biomarker in gastric cancer by bioinformatics analysis.
Wang G; Ren Z; Zhao Y; Li Y
Clin Transl Oncol; 2023 Nov; 25(11):3296-3306. PubMed ID: 37041435
[TBL] [Abstract] [Full Text] [Related]
4. Fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT) regimen in the first-line treatment of metastatic gastric cancer: A single-center experience.
Tastekin D; Paksoy N; Dogan I; Ferhatoglu F; Khanmammadov N; Bozbey HU; Karabulut S
J Cancer Res Ther; 2023; 19(2):253-258. PubMed ID: 37006064
[TBL] [Abstract] [Full Text] [Related]
5. Identification of tumor mutation burden-associated molecular and clinical features in cancer by analyzing multi-omics data.
Li M; Gao X; Wang X
Front Immunol; 2023; 14():1090838. PubMed ID: 36911742
[TBL] [Abstract] [Full Text] [Related]
6. Comprehensive Analysis of Prognostic Factors in Advanced gastric cancer Patients Treated with Chemotherapy.
Cavdar E; Iriagac Y; Avci O; Seber ES
J Coll Physicians Surg Pak; 2022 Nov; 32(11):1420-1424. PubMed ID: 36377008
[TBL] [Abstract] [Full Text] [Related]
7. The Effect of HALP Score on the prognosis of gastric Adenocarcinoma.
Sargin ZG; Dusunceli I
J Coll Physicians Surg Pak; 2022 Sep; 32(9):1154-1159. PubMed ID: 36089712
[TBL] [Abstract] [Full Text] [Related]
8. Metabolic syndrome, obesity and cancer risk.
Belladelli F; Montorsi F; Martini A
Curr Opin Urol; 2022 Nov; 32(6):594-597. PubMed ID: 36081396
[TBL] [Abstract] [Full Text] [Related]
9. prognosis of gastric adenocarcinoma associated with girdin, Akt, and cortactin.
Zhang Y; Liu C; Zhou L
Ann Saudi Med; 2022; 42(3):181-190. PubMed ID: 35770962
[TBL] [Abstract] [Full Text] [Related]
10. Pepsinogen/Proton Pump Co-Expression in Barrett's Esophageal Cells Induces cancer-Associated Changes.
Stabenau KA; Samuels TL; Lam TK; Mathison AJ; Wells C; Altman KW; Battle MA; Johnston N
Laryngoscope; 2023 Jan; 133(1):59-69. PubMed ID: 35315085
[TBL] [Abstract] [Full Text] [Related]
11. Hip Fractures in Patients With Liver Cirrhosis: Worsening Liver Function Is Associated with Increased Mortality.
Hundersmarck D; Groot OQ; Schuijt HJ; Hietbrink F; Leenen LPH; Heng M
Clin Orthop Relat Res; 2022 Jun; 480(6):1077-1088. PubMed ID: 34978539
[TBL] [Abstract] [Full Text] [Related]
12. Validation of a Nomogram to Predict Long Term Outcomes After Curative Surgery for gastric cancer in an Italian Cohort of Patients.
Capelli G; Tonello AS; Chiminazzo V; Lorenzoni G; Bao QR; Marchet A; Gregori D; Pawlik TM; Pucciarelli S; Spolverato G
J Visc Surg; 2022 Dec; 159(6):471-479. PubMed ID: 34794901
[TBL] [Abstract] [Full Text] [Related]
13. Negative-to-Positive Lymph Node Ratio as an Independent Prognostic Factor for gastric Adenocarcinoma.
Alakus H; Kaya M; Mollaoglu MC; Göksu M; Ozer H; Karadayi K
J Coll Physicians Surg Pak; 2021 Jul; 31(7):805-810. PubMed ID: 34271780
[TBL] [Abstract] [Full Text] [Related]
14. Expressions of Putative cancer Stem Cell Markers, CD44 and CD133, are Correlated with Pathological Tumour Stage in gastric Adenocarcinoma.
Duzcu SE; Astarci HM; Tunc N; Boran C
J Coll Physicians Surg Pak; 2021 May; 31(5):553-558. PubMed ID: 34027868
[TBL] [Abstract] [Full Text] [Related]
15. Short-term Prognostic Value of Tumor Diameter in Stage 2 and 3 gastric cancer.
Uzunoglu H; Kaya S
J Coll Physicians Surg Pak; 2021 Mar; 31(3):288-293. PubMed ID: 33775017
[TBL] [Abstract] [Full Text] [Related]
16. An Evaluation of the Effect of Preoperative Inflammation-based Factors on Survival in gastric cancer Patients.
Durhan A; Senlikci A; Kosmaz K; Erguder E; Mercan U; Suleyman M
J Coll Physicians Surg Pak; 2021 Mar; 31(3):282-287. PubMed ID: 33775016
[TBL] [Abstract] [Full Text] [Related]
17. Prognostic Role of Red Distribution Width (RDW) Value in gastric cancer.
Yüksel C; Erşen O; Culcu S; Bakırarar B; Unal AE; Demirci S
J Coll Physicians Surg Pak; 2021 Jan; 31(1):21-26. PubMed ID: 33546528
[TBL] [Abstract] [Full Text] [Related]
18. [Persistence of Epstein-Barr virus antigens in gastric cancer: characteristic of inflammatory cellular reactions in tumor].
Danilova NV; Mikhailov IA; Oleynikova NA; Malkov PG; Chayka AV; Khomyakov VM; Kakotkin VV; Yudin MY
Arkh Patol; 2021; 83(1):18-24. PubMed ID: 33512123
[TBL] [Abstract] [Full Text] [Related]
19. Response to Trastuzumab Treatment and Number of Cycles ın Her2-Positive Metastatic gastric cancer Survival.
Bugdayci Basal F; Karacin C; Bilgetekin I; Oksuzoglu OB; Demirci U
J Coll Physicians Surg Pak; 2020 Dec; 30(12):1279-1284. PubMed ID: 33397053
[TBL] [Abstract] [Full Text] [Related]
20. Advances in the treatment of gastric cancer.
Ilson DH
Curr Opin Gastroenterol; 2020 Nov; 36(6):525-529. PubMed ID: 32889823
[TBL] [Abstract] [Full Text] [Related]
[Next]
